Drugs / Paclitaxel micelles
last change Mar 2026 re-read 3 minutes ago

Paclitaxel micelles

Developed for
esophageal squamous cell carcinoma
Investigated by
Fudan University

Trials 1

202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT07469241 Mar 2026 → Dec 2028 expected esophageal squamous cell carcinoma Fudan University Not yet recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Paclitaxel micelles “TPF (Paclitaxel micelles or albumin-bound paclitaxel 100 mg/m2, cisplatin 30 mg/m2, fluorouracil 200 mg/m2 IV drip + 1000 mg/m2 pump for 44 hours, leucovorin/calcium 200 mg) +...” NCT07469241 ↗